These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3153333

  • 41. [The treatment of children with idiopathic nephrotic syndrome using cyclosporin].
    Donckerwolcke RA, Vande Walle JG.
    Ned Tijdschr Geneeskd; 1992 Sep 05; 136(36):1770-4. PubMed ID: 1407127
    [Abstract] [Full Text] [Related]

  • 42. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
    Nephrol Dial Transplant; 2005 Apr 05; 20(4):735-42. PubMed ID: 15772265
    [Abstract] [Full Text] [Related]

  • 43. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
    Kim PK, Kim KS, Pai KS, Kim JH, Choi IJ.
    Yonsei Med J; 1997 Oct 05; 38(5):307-18. PubMed ID: 9409194
    [Abstract] [Full Text] [Related]

  • 44. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
    Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.
    Clin Nephrol; 2004 Jan 05; 61(1):17-24. PubMed ID: 14964453
    [Abstract] [Full Text] [Related]

  • 45. Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome.
    Iijima K, Hamahira K, Kobayashi A, Nakamura H, Yoshikawa N.
    J Am Soc Nephrol; 2000 Dec 05; 11(12):2265-2271. PubMed ID: 11095649
    [Abstract] [Full Text] [Related]

  • 46. Remission of steroid- and CyA-resistant nephrotic syndrome using multiple drug immunosuppression.
    Ulinski T, Perrin L, Guigonis V, Driss F, Deschênes G, Bensman A.
    Pediatr Nephrol; 2007 Oct 05; 22(10):1723-6. PubMed ID: 17636340
    [Abstract] [Full Text] [Related]

  • 47. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K, Ito H, Anzai M, Matsumura C, Kurayama H.
    J Nephrol; 2013 Oct 05; 26(2):306-14. PubMed ID: 22641570
    [Abstract] [Full Text] [Related]

  • 48. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
    Kawasaki Y, Hosoya M, Kobayashi S, Ohara S, Onishi N, Takahashi A, Isome M, Suzuki H.
    Nephrol Dial Transplant; 2005 Oct 05; 20(10):2243-7. PubMed ID: 16030039
    [Abstract] [Full Text] [Related]

  • 49. Late nonresponsiveness to steroids in children with the nephrotic syndrome.
    Trainin EB, Boichis H, Spitzer A, Edelmann CM, Greifer I.
    J Pediatr; 1975 Oct 05; 87(4):519-23. PubMed ID: 1159578
    [Abstract] [Full Text] [Related]

  • 50. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
    Windom HH, Fisher M, Neale TJ.
    N Z Med J; 1990 Mar 28; 103(886):125-6. PubMed ID: 2320338
    [Abstract] [Full Text] [Related]

  • 51. Management of nephrotic syndrome in childhood.
    Melvin T, Bennett W.
    Drugs; 1991 Jul 28; 42(1):30-51. PubMed ID: 1718684
    [Abstract] [Full Text] [Related]

  • 52. Predictive factors for ciclosporin-associated nephrotoxicity in children with minimal change nephrotic syndrome.
    Kim JH, Park SJ, Yoon SJ, Lim BJ, Jeong HJ, Lee JS, Kim PK, Shin JI.
    J Clin Pathol; 2011 Jun 28; 64(6):516-9. PubMed ID: 21441261
    [Abstract] [Full Text] [Related]

  • 53. Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome.
    Hulton SA, Jadresic L, Shah V, Trompeter RS, Dillon MJ, Barratt TM.
    Pediatr Nephrol; 1994 Aug 28; 8(4):404-7. PubMed ID: 7947024
    [Abstract] [Full Text] [Related]

  • 54. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Habashy D, Hodson E, Craig J.
    Cochrane Database Syst Rev; 2004 Aug 28; (2):CD003594. PubMed ID: 15106208
    [Abstract] [Full Text] [Related]

  • 55. The significance of focal global sclerosis in idiopathic nephrotic syndrome. Long-term clinical observations.
    Querfeld U, Waldherr R, Schärer K.
    Acta Paediatr Scand; 1985 Nov 28; 74(6):913-9. PubMed ID: 4090967
    [Abstract] [Full Text] [Related]

  • 56. Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study.
    Sureshkumar P, Hodson EM, Willis NS, Barzi F, Craig JC.
    Pediatr Nephrol; 2014 Jun 28; 29(6):1039-46. PubMed ID: 24488504
    [Abstract] [Full Text] [Related]

  • 57. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
    Nephrol Dial Transplant; 2006 Nov 28; 21(11):3127-32. PubMed ID: 16968719
    [Abstract] [Full Text] [Related]

  • 58. Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group.
    Lande MB, Gullion C, Hogg RJ, Gauthier B, Shah B, Leonard MB, Bonilla-Felix M, Nash M, Roy S, Strife CF, Arbus G.
    Pediatr Nephrol; 2003 Apr 28; 18(4):342-6. PubMed ID: 12700959
    [Abstract] [Full Text] [Related]

  • 59. Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor.
    Wasilewska A, Zoch-Zwierz W, Pietruczuk M.
    Eur J Pediatr; 2007 May 28; 166(5):447-52. PubMed ID: 17024347
    [Abstract] [Full Text] [Related]

  • 60. [Cyclosporine in the treatment of glomerular diseases in children].
    Peco-Antić A, Popović-Rolović M, Jovanović O, Kostić M, Popović D.
    Srp Arh Celok Lek; 1992 May 28; 120(3-4):132-6. PubMed ID: 1465661
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.